
PTC Therapeutics PTCT
$ 66.88
-3.05%
Annual report 2025
added 02-19-2026
PTC Therapeutics Total Inventories 2011-2026 | PTCT
Annual Total Inventories PTC Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79.6 M | 23.2 M | 30.6 M | 21.8 M | 15.9 M | 18.7 M | 19.3 M | 16.1 M | 10.8 M | 1.7 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.6 M | 1.7 M | 23.8 M |
Quarterly Total Inventories PTC Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.7 M | 34.1 M | 21.7 M | 23.2 M | 35.7 M | 31.8 M | 30.1 M | 30.6 M | 35.8 M | 32 M | 26.6 M | 21.8 M | 14.8 M | - | 15.3 M | 15.9 M | 15.6 M | 16.4 M | 16.2 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 52.7 M | 10.8 M | 21.5 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.81 | 0.15 % | $ 4.42 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
BioMarin Pharmaceutical
BMRN
|
1.23 B | $ 61.58 | -1.66 % | $ 11.7 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 165.14 | -2.83 % | $ 8.22 B | ||
|
CASI Pharmaceuticals
CASI
|
1.91 M | $ 0.31 | -61.59 % | $ 42.2 M | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
4.28 M | $ 12.21 | -3.48 % | $ 804 M | ||
|
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
2.17 B | $ 191.78 | -1.72 % | $ 28.1 B | ||
|
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | ||
|
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.64 | -0.17 % | $ 4.52 B |